Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm.

Area of Science:

• Endocrinology
• Immunology
• Thoracic Medicine

Background:

• The association between Graves' disease (GD) and thymic hyperplasia (TH) has been recognized since 1912.
• Thymic hyperplasia in GD often appears as an incidental mediastinal mass on imaging.
• The exact pathogenesis of TH in GD involves complex hormonal and immunological factors.

Purpose of the Study:

• To review the impact of thyroid hormones and autoimmunity on thymic growth.
• To highlight the unfamiliarity of general physicians with the GD-TH association.
• To discuss diagnostic workup and differential diagnosis for thymic enlargement in GD patients.

Main Methods:

• Review of the effect of thyroid hormones and autoimmunity on thymic size.
• Analysis of authors' experience and published case reports.
• Evaluation of clinical evidence for diagnostic and management strategies.

Main Results:

• Recent literature confirms the generally benign nature of TH associated with GD.
• A conservative approach to diagnostic workup and initial management is supported.
• Lack of physician familiarity may lead to aggressive, potentially unnecessary, interventions.

Conclusions:

• Thymic hyperplasia in Graves' disease is typically benign.
• Conservative management and workup are recommended.
• Practical management recommendations are provided for clinicians.